Delivery Order SPE2DB20D2001-SPE2DB25FPMWU
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,768.30 to AmerisourceBergen Drug Corp for the supply of ELIQUIS 2.5 mg tablets (60-count units) under a firm fixed price contract. The award was issued on August 5, 2025, with an ultimate completion date of August 6, 2025. This is a non-set-aside, competitively awarded delivery order with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for ELIQUIS 5 mg tablets (60-count supply) with a ceiling value of $44,667.59. This firm fixed-price delivery order, issued on May 30, 2025, with completion scheduled for June 2, 2025, represents a non-set-aside competitive award to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,931.20 to AmerisourceBergen Drug Corp for the supply of ELIQUIS 2.5 mg tablets (60-count) under a firm fixed price contract. The award was made on June 2, 2025, with an ultimate completion date of June 3, 2025, and will be performed at the vendor's facility in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside, competitively awarded procurement and is issued as a child contract under...
- The Defense Logistics Agency awarded a $2,751.64 delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Eliquis 5 mg tablets (60-count packages). This competitively awarded, firm fixed-price contract is classified as a non-set-aside procurement with an ultimate completion date of June 26, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical federal medical supply vendor for military and...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) for ELIQUIS 5 mg tablets (60 count) with a ceiling value of $28,889.03 and a firm fixed price structure. The award was issued on July 22, 2025, with an ultimate completion date of July 23, 2025. The contract contains no set-aside designation and was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units) under a firm fixed-price contract valued at $5,896.80. The order was competitively awarded without set-aside designation and has an ultimate completion date of August 19, 2025. AmerisourceBergen will perform this delivery from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $17,006.14 delivery order to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed price contract. The award was issued on July 30, 2025, with a completion date of July 31, 2025, and represents a competitively awarded, non-set-aside contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $1,638.00 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count packages) on August 12, 2025, with completion scheduled for August 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs,...
- The Defense Logistics Agency awarded a $1,965.60 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 2.5 mg, a firm fixed price contract with an ultimate completion date of August 26, 2025. This non-set-aside award reflects a competitive procurement and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical federal vendor specializing in comprehensive medical supply...
- The Defense Logistics Agency awarded a delivery order valued at $25,380.07 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) with a firm fixed price contract type. The award was competitively procured with no set-aside designation and is scheduled for completion by June 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this delivery order, which falls under the company's existing Indefinite...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB25FPMWUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of ELIQUIS 2.5 mg tablets (60-count) valued at $4,289.88. This is a competitively awarded, non-set-aside firm fixed-price contract with an ultimate completion date of June 9, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.99 billion ceiling value and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. As a registered SAM.gov vendor, the company demonstrates substantial capability in fulfilling federal medical supply requirements across multiple therapeutic domains through open competition. The company serves multiple federal customers including the Defense Health Agency and U.S. Coast Guard, positioning itself as a key provider within the DLA's pharmaceutical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.3k | 6/6/25 |